SEC Company Response from Ensysce Biosciences, Inc. (ENSC, ENSCW) (CIK 0001716947) (ENSC) — Dec 1, 2017
Ensysce Biosciences, Inc. (ENSC, ENSCW) (CIK 0001716947)
Date: Dec. 1, 2017 · CIK: 0001716947 · Accession: 0001144204-17-061787
AI Filing Summary & Sentiment
File numbers found in text: 333-221330
Show Raw Text
CORRESP
1
filename1.htm
LEISURE ACQUISITION CORP.
250 West 57th Street, Suite 2223
New York, New York 10107
December 1, 2017
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-1004
Attention: Larry Spirgel
Re: Leisure Acquisition Corp.
Registration Statement on Form S-1 (File
No. 333-221330)
Acceleration Request:
Requested Date: December 1, 2017
Requested Time: 9:00 AM Eastern Time
Dear Mr. Spirgel:
On November 28, 2017, Leisure Acquisition
Corp. (the “Company”) requested acceleration of the effective date of the above-referenced Registration Statement
on Form S-1 (File No. 333-221330) (the “Registration Statement”) so that it would become effective at 3:00 p.m.
(New York time) on November 30, 2017, or as soon thereafter as practicable.
Pursuant to Rule 461 of Regulation C promulgated
under the Securities Act of 1933, as amended, the Company hereby instead requests the the acceleration of the effective date of
the Registration Statement so that it may become effective at the “Requested Date” and “Requested Time”
set forth above, or as soon thereafter as practicable.
[Signature page follows]
LEISURE ACQUSITION CORP.
By:
/s/ Daniel B. Silvers
Name:
Daniel B. Silvers
Title:
Chief Executive Officer
[Signature
Page – Company Acceleration Request]